Sign In
Buy INSM
$103.86
+0.130 (+0.125%)
At Close: Jun 03, 2026
Insmed Announces Pricing of Public Offering of Common Stock
12:00pm, Tuesday, 05'th May 2020
Insmed Incorporated (Nasdaq: INSM) announced today that it priced a registered underwritten public offering of 9,700,000 shares of its common stock at a price to the public of $23.25 per share. The gr
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks hitting 52-week highs May 5.)
Arcturus Therapeutics Ltd (...
Insmed Announces Proposed Public Offering of Common Stock
08:01pm, Monday, 04'th May 2020
Insmed Incorporated (Nasdaq: INSM) announced today that it intends to offer and sell shares of its common stock in an underwritten public offering. In addition, Insmed intends to grant the underwriter
Insmed Incorporated (NASDAQ:INSM) Just Reported And Analysts Have Been Cutting Their Estimates
10:49am, Monday, 04'th May 2020
As you might know, Insmed Incorporated (NASDAQ:INSM) recently reported its first-quarter numbers. It looks like a...
Insmed (INSM) Q1 2020 Earnings Call Transcript
07:01pm, Friday, 01'st May 2020
INSM earnings call for the period ending March 31, 2020.
H.C. Wainwright Keeps Their Buy Rating on Insmed (INSM)
11:23am, Friday, 01'st May 2020
H.C. Wainwright analyst Andrew Fein maintained a Buy rating on Insmed (INSM) today and set a price target of $52.00. The company's shares closed last
H.C. Wainwright Keeps Their Buy Rating on Insmed (INSM)
11:23am, Friday, 01'st May 2020
H.C. Wainwright analyst
Andrew Fein
maintained a
Buy
rating on Insmed (
INSM
–
Research Report
) today and set a price target of
$52.00
. The company’s shares closed last Thursday at $23.00.
Accor
Edited Transcript of INSM earnings conference call or presentation 30-Apr-20 12:30pm GMT
07:35am, Friday, 01'st May 2020
Q1 2020 Insmed Inc Earnings Call
Insmed Incorporated (INSM) CEO Will Lewis on Q1 2020 Results - Earnings Call Transcript
07:01pm, Thursday, 30'th Apr 2020
Insmed Incorporated (NASDAQ:INSM) Q1 2020 Results Conference Call April 30, 2020 08:30 AM ET Company Participants Sara Bonstein - CFO Will Lewis - Chairman and
Insmed (INSM) Reports Q1 Loss, Tops Revenue Estimates
01:05pm, Thursday, 30'th Apr 2020
Insmed (INSM) delivered earnings and revenue surprises of -10.45% and 9.20%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Insmed (INSM) Reports Q1 Loss, Tops Revenue Estimates
01:05pm, Thursday, 30'th Apr 2020
Insmed (INSM) delivered earnings and revenue surprises of -10.45% and 9.20%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Recap: Insmed Q1 Earnings
12:58pm, Thursday, 30'th Apr 2020
Shares of Insmed (NASDAQ:INSM) were unchanged at $21.05 after the company reported Q1 results.Quarterly Results Earnings per share increased 22.92% year over year to ($0.74), which missed the estimate
Analysts Expect Breakeven For Insmed Incorporated (NASDAQ:INSM)
12:32pm, Thursday, 30'th Apr 2020
Insmed Incorporated's (NASDAQ:INSM): Insmed Incorporated, a biopharmaceutical company, focuses on the development and...
Insmed: 1Q Earnings Snapshot
11:54am, Thursday, 30'th Apr 2020
BRIDGEWATER, N.J. (AP) _ Insmed Inc. (INSM) on Thursday reported a loss of $66.4 million in its first quarter.
On a per-share basis, the Bridgewater, New Jersey-based company said it had a loss of 74
Insmed Reports First Quarter 2020 Financial Results and Provides Business Update
11:30am, Thursday, 30'th Apr 2020
Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today reported financial results for the first qua
